Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CEN and CENELEC receive draft standards mandate on IVDs

This article was originally published in Clinica

Executive Summary

CEN and CENELEC have received a draft mandate from the European Commission to develop a programme of standards needed to support the IVD-MD Directive, currently in draft. In response, CEN BTS 3 Healthcare has set up an ad hoc group to co-ordinate programming. It will liaise with CEN TC 140 and CENELEC TCs 62 and 66 to draw up a list of proposed standards which will indicate conformity with the Essential Requirements of the Directive. It plans to complete the proposed programme by November, after which it will be sent to the Commission for approval.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT091958

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel